If the import of genes modified for clinical trials is directly linked to future taxable transactions, the VAT paid at customs by the company upon importing the goods in question can be considered a cost related to the taxable transactions, which confer the right to the deduction, which will be made by the Company.
In order to exercise the right to deduct VAT, it is not necessary for the taxable person to be the owner of the imported goods , but it is necessary that these goods have an immediate and direct connection with the object of the activity carried out. With this ruling, the Revenue Agency confirmed a principle already expressed, among others, in resolution no. 96.
Sources:
